2,767
edits
Psychedelics: Difference between revisions
m
→Long Term Effects
mNo edit summary |
|||
| Line 71: | Line 71: | ||
== Long Term Effects == | == Long Term Effects == | ||
<div class="res-img">[[File:Cognitive Dissonance2.png|alt=Cognitive Dissonance|center|Cognitive dissonance quote]]</div> | |||
[[File:Psychedelics relative harm.jpg|alt=Economist relative harm|thumb|'''Figure 3'''. Relative harm of drugs<ref>'''Drug harms in the UK''': a multicriteria decision analysis Prof David J Nutt, FMedSci, Leslie A King, PhD, Lawrence D Phillips, PhD on behalf of the Independent Scientific Committee on Drugs Published:November 01, 2010. DOI:https://doi.org/10.1016/S0140-6736(10)61462-6</ref>.]] | [[File:Psychedelics relative harm.jpg|alt=Economist relative harm|thumb|'''Figure 3'''. Relative harm of drugs<ref>'''Drug harms in the UK''': a multicriteria decision analysis Prof David J Nutt, FMedSci, Leslie A King, PhD, Lawrence D Phillips, PhD on behalf of the Independent Scientific Committee on Drugs Published:November 01, 2010. DOI:https://doi.org/10.1016/S0140-6736(10)61462-6</ref>.]] | ||
Like all medicines, psychedelics are not without potential harm. However, relative to all other drugs (See '''Figure 3''') risk associated with their use is minimal. In a clinical sense, under specific [[priming]], [[setting]] and [[integration]] there is abundant evidence for the safety and efficacy for their use in the treatment of: | Like all medicines, psychedelics are not without potential harm. However, relative to all other drugs (See '''Figure 3''') risk associated with their use is minimal. In a clinical sense, under specific [[priming]], [[setting]] and [[integration]] there is abundant evidence for the safety and efficacy for their use in the treatment of: | ||
| Line 82: | Line 83: | ||
**'''Hyper-Consumerism''' - several peer-reviewed studies have shown that psychedelics also work as ''[[ecodelics]]'', medicines which can induce ecological concern<ref>'''Catalysts for Transformation: A systematic literature review exploring the interlinkages and potential role of classic psychedelics to social-ecological sustainability.''' Marion Nilsson, Lund University Centre for Sustainability Studies. Accessed on 30 January 2023 via: https://lup.lub.lu.se/luur/download?fileOId=9031166&func=downloadFile&recordOId=9031164</ref><ref>'''Accidental Environmentalism: Nature and Cultivated Affect in European Neoshamanic Ayahuasca Consumption'''. Arne Harms University of Leipzig. Accessed on 30 Jan 2023 via https://www.proquest.com/openview/e872aeede38122f158ef3d84fbc39c38/1?cbl=18750</ref><ref>'''Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies'''. Studerus E, Kometer M, Hasler F, Vollenweider FX. J Psychopharmacol. 2011 Nov;25(11):1434-52. doi: 10.1177/0269881110382466. Epub 2010 Sep 20. PMID: 20855349. Accessed on 12 December 2022 via: https://pubmed.ncbi.nlm.nih.gov/20855349/</ref><ref>'''Connectedness to Nature and to Humanity: their association and personality correlates'''. Front. Psychol., 21 July 2015. Sec. Personality and Social Psychology. Kibeom Lee, Michael C. Ashton, Julie Choi and Kayla Zachariassen. https://doi.org/10.3389/fpsyg.2015.01003. Accessed on 3rd October 2022 via https://www.frontiersin.org/articles/10.3389/fpsyg.2015.01003/full</ref><ref>'''Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression'''. Journal of Psychopharmacology. Taylor Lyons, Robin L Carhart-Harris. https://doi.org/10.1177/0269881117748902. Accessed on 3rd October 2022 via https://journals.sagepub.com/doi/full/10.1177/0269881117748902</ref><ref>'''Psychedelics, Personality and Political Perspectives'''. Matthew M Nour 1, Lisa Evans 2, Robin L Carhart-Harris DOI: 10.1080/02791072.2017.1312643. 2017 Jul-Aug;49(3):182-191. doi: 10.1080/02791072.2017.1312643. Epub 2017 Apr 26. Accessed on 3rd October 2022 via https://pubmed.ncbi.nlm.nih.gov/28443703/</ref><ref name=":1">'''''Manifesting Minds: A Review of Psychedelics in Science, Medicine, Sex, and Spirituality'''''. Doblin, Rick; Brad Burge (2014) North Atlantic Books. <nowiki>ISBN 1583947272</nowiki>.</ref><ref name=":2">'''Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness'''. Matthias Forstmann and Christina Sagioglou Journal of Psychopharmacology 2017. DOI: 10.1177/0269881117714049. Accessed on 30th September 2022 via: https://pubmed.ncbi.nlm.nih.gov/28631526/</ref><ref name=":3">'''From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner'''. Hannes Kettner, Sam Gandy, Eline C. H. M. Haijen and Robin L. Carhart-Harris Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London. International Journal of Environmental Research and Public Health. Published: December 2019 DOI: 10.3390/ijerph16245147. Accessed on 30th September 2022 via: https://pubmed.ncbi.nlm.nih.gov/31888300/ | **'''Hyper-Consumerism''' - several peer-reviewed studies have shown that psychedelics also work as ''[[ecodelics]]'', medicines which can induce ecological concern<ref>'''Catalysts for Transformation: A systematic literature review exploring the interlinkages and potential role of classic psychedelics to social-ecological sustainability.''' Marion Nilsson, Lund University Centre for Sustainability Studies. Accessed on 30 January 2023 via: https://lup.lub.lu.se/luur/download?fileOId=9031166&func=downloadFile&recordOId=9031164</ref><ref>'''Accidental Environmentalism: Nature and Cultivated Affect in European Neoshamanic Ayahuasca Consumption'''. Arne Harms University of Leipzig. Accessed on 30 Jan 2023 via https://www.proquest.com/openview/e872aeede38122f158ef3d84fbc39c38/1?cbl=18750</ref><ref>'''Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies'''. Studerus E, Kometer M, Hasler F, Vollenweider FX. J Psychopharmacol. 2011 Nov;25(11):1434-52. doi: 10.1177/0269881110382466. Epub 2010 Sep 20. PMID: 20855349. Accessed on 12 December 2022 via: https://pubmed.ncbi.nlm.nih.gov/20855349/</ref><ref>'''Connectedness to Nature and to Humanity: their association and personality correlates'''. Front. Psychol., 21 July 2015. Sec. Personality and Social Psychology. Kibeom Lee, Michael C. Ashton, Julie Choi and Kayla Zachariassen. https://doi.org/10.3389/fpsyg.2015.01003. Accessed on 3rd October 2022 via https://www.frontiersin.org/articles/10.3389/fpsyg.2015.01003/full</ref><ref>'''Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression'''. Journal of Psychopharmacology. Taylor Lyons, Robin L Carhart-Harris. https://doi.org/10.1177/0269881117748902. Accessed on 3rd October 2022 via https://journals.sagepub.com/doi/full/10.1177/0269881117748902</ref><ref>'''Psychedelics, Personality and Political Perspectives'''. Matthew M Nour 1, Lisa Evans 2, Robin L Carhart-Harris DOI: 10.1080/02791072.2017.1312643. 2017 Jul-Aug;49(3):182-191. doi: 10.1080/02791072.2017.1312643. Epub 2017 Apr 26. Accessed on 3rd October 2022 via https://pubmed.ncbi.nlm.nih.gov/28443703/</ref><ref name=":1">'''''Manifesting Minds: A Review of Psychedelics in Science, Medicine, Sex, and Spirituality'''''. Doblin, Rick; Brad Burge (2014) North Atlantic Books. <nowiki>ISBN 1583947272</nowiki>.</ref><ref name=":2">'''Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness'''. Matthias Forstmann and Christina Sagioglou Journal of Psychopharmacology 2017. DOI: 10.1177/0269881117714049. Accessed on 30th September 2022 via: https://pubmed.ncbi.nlm.nih.gov/28631526/</ref><ref name=":3">'''From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner'''. Hannes Kettner, Sam Gandy, Eline C. H. M. Haijen and Robin L. Carhart-Harris Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London. International Journal of Environmental Research and Public Health. Published: December 2019 DOI: 10.3390/ijerph16245147. Accessed on 30th September 2022 via: https://pubmed.ncbi.nlm.nih.gov/31888300/ | ||
</ref>. | </ref>. | ||
Emotions and brain function are altered up to one month after a single high dose of psilocybin<ref>'''Emotions and brain function are altered up to one month after a single high dose of psilocybin.''' Barrett, F.S., Doss, M.K., Sepeda, N.D. ''et al.'' ''Sci Rep'' 10, 2214 (2020). <nowiki>https://doi.org/10.1038/s41598-020-59282-y</nowiki></ref>. Psychedelic use correlates to lifetimes without [[depression]]<ref>'''Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.''' Grant M Jones., Matthew K Nock. Published January 5, 2022 in Volume 36, Issue 1 of Journal of Psychopharmacology. https://doi.org/10.1177/026988112</ref>. Numerous studies<ref>'''Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.''' Eduardo Ekman Schenberg. Front Pharmacol. 2018; 9: 733. Published online 2018 Jul 5. doi: 10.3389/fphar.2018.00733.</ref> and a systematic review<ref>'''A systematic review of psychedelic-assisted psychotherapy for mental health''': An evaluation of the current wave of research and suggestions for the future. Wheeler, S. W., & Dyer, N. L. (2020). Psychology of Consciousness: Theory, Research, and Practice, 7(3), 279–315. <nowiki>https://doi.org/10.1037/cns0000237</nowiki></ref> have concluded that [[Guided Psychedelic Therapy|guided psychedelic therapy]] can further improve the above therapeutic effects. | Emotions and brain function are altered up to one month after a single high dose of psilocybin<ref>'''Emotions and brain function are altered up to one month after a single high dose of psilocybin.''' Barrett, F.S., Doss, M.K., Sepeda, N.D. ''et al.'' ''Sci Rep'' 10, 2214 (2020). <nowiki>https://doi.org/10.1038/s41598-020-59282-y</nowiki></ref>. Psychedelic use correlates to lifetimes without [[depression]]<ref>'''Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.''' Grant M Jones., Matthew K Nock. Published January 5, 2022 in Volume 36, Issue 1 of Journal of Psychopharmacology. https://doi.org/10.1177/026988112</ref>. Numerous studies<ref>'''Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.''' Eduardo Ekman Schenberg. Front Pharmacol. 2018; 9: 733. Published online 2018 Jul 5. doi: 10.3389/fphar.2018.00733.</ref> and a systematic review<ref>'''A systematic review of psychedelic-assisted psychotherapy for mental health''': An evaluation of the current wave of research and suggestions for the future. Wheeler, S. W., & Dyer, N. L. (2020). Psychology of Consciousness: Theory, Research, and Practice, 7(3), 279–315. <nowiki>https://doi.org/10.1037/cns0000237</nowiki></ref> have concluded that [[Guided Psychedelic Therapy|guided psychedelic therapy]] can further improve the above therapeutic effects. | ||
== Mechanism of Action == | == Mechanism of Action == | ||